Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Tildrakizumab Shows Real World Gains in Plaque Psoriasis
January 2026
Real-world meta-analysis found tildrakizumab substantially improved plaque psoriasis severity and quality of life through 52 weeks.
Read more
8 Jan 2026
Tildrakizumab Shows Real World Gains in Plaque Psoriasis
Real-world meta-analysis found tildrakizumab substantially improved plaque psoriasis severity and quality of life through 52 weeks.
5 Jan 2026
Indoor Tanning Behaves Like Smoking for Skin
Indoor tanning bed use substantially raises melanoma, BCC, and cSCC risks, underscoring this well-established carcinogenic profile.
1 Jan 2026
Tinea Capitis Outcomes Worsen with Nutrient Deficiencies
In children, deficiencies in zinc and vitamin D independently increased tinea capitis risk and lowered 8-week clinical cure rates.
29 Dec 2025
Hidradenitis Suppurativa Biologics Show Early Differences
Bimekizumab showed the strongest short-term efficacy among hidradenitis suppurativa biologics in trials assessed at Week 12 to 16.
26 Dec 2025
Systemic Lupus Erythematosus with Chronic Spontaneous Urticaria Risk
Chronic spontaneous urticaria in SLE was not linked to higher disease activity, but was associated with distinct clinical and laboratory risk factors.
25 Dec 2025
Large Spot Picosecond Laser Treatment for Pigmented Lesions
Large spot picosecond lasers potentially improve dermal pigment clearance in Asian skin while reducing perilesionaltissue exposure.
19 Dec 2025
Abrocitinib Treatment Adjusted for Atopic Dermatitis
Abrocitinib treatment can be personalized in moderate-to-severe atopic dermatitis using flexible dosing to meet disease trajectory.
17 Dec 2025
Study Finds Variability in ChatGPT-Informed Consent Forms
A cross-sectional study has found variability in how ChatGPT performs when asked to generate informed consent forms for cosmetic dermatology procedures that use lasers and energy-based devices.
Loading posts...
1
2
3
…
21
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View